Cite
MLA Citation
Susanna Hegewisch-Becker et al.. “Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.” Lancet oncology, vol. 16, no. 13, 2015, pp. 1355–1369. http://access.bl.uk/ark:/81055/vdc_100050920025.0x000017